新里程收盘下跌1.80%，滚动市盈率65.86倍，总市值73.84亿元

Core Viewpoint - New Mile's stock closed at 2.18 yuan on August 4, down 1.80%, with a rolling PE ratio of 65.86 times and a total market value of 7.384 billion yuan [1] Group 1: Company Overview - New Mile Health Technology Group Co., Ltd. specializes in medical services and pharmaceutical manufacturing, focusing on drug production for over 20 years [1] - The company's main products include pharmaceuticals and medical services, with the "Duyiwei" brand as its core series of traditional Chinese medicine [1] - "Duyiwei Capsule" is included in the 2020 edition of the "Chinese Pharmacopoeia" and is recognized as a national basic drug, featuring unique efficacy, high safety, and low treatment costs [1] Group 2: Financial Performance - In the first quarter of 2025, the company reported operating revenue of 796 million yuan, a year-on-year decrease of 16.49%, and a net profit of 25.652 million yuan, down 9.35% year-on-year, with a gross profit margin of 27.96% [1] Group 3: Industry Comparison - The average PE ratio for the medical services industry is 47.79 times, with a median of 59.03 times, placing New Mile at the 32nd position in the industry ranking [2] - The company's static PE ratio is 64.34 times, and its price-to-book ratio is 3.66 times [2]